Quick Answer
Pacira BioSciences, Inc. reported Diluted EPS of $0.16 per share for fiscal year 2025.
Pacira BioSciences, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.16 | +107.4% |
| 2024 | -$2.15 | -341.6% |
| 2023 | $0.89 | +161.8% |
| 2022 | $0.34 | -63.0% |
| 2021 | $0.92 | -72.4% |
| 2020 | $3.33 | +1333.3% |
| 2019 | -$0.27 | -2600.0% |
| 2018 | -$0.01 | +99.1% |
| 2017 | -$1.07 | -4.9% |
| 2016 | -$1.02 | -2650.0% |
| 2015 | $0.04 | +110.3% |
| 2014 | -$0.39 | +79.8% |
| 2013 | -$1.93 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.12 | +103.9% | +209.1% |
| June 30, 2025 | -$0.11 | -128.2% | -210.0% |
| March 31, 2025 | $0.10 | -47.4% | +103.2% |
| September 30, 2024 | -$3.11 | -1452.2% | -897.4% |
| June 30, 2024 | $0.39 | -23.5% | +105.3% |
| March 31, 2024 | $0.19 | +144.2% | -17.4% |
| September 30, 2023 | $0.23 | +1250.0% | -54.9% |
| June 30, 2023 | $0.51 | +27.5% | +218.6% |
- Pacira BioSciences, Inc. showed an increase of +107.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2013–2025 period, Pacira BioSciences, Inc.’s diluted eps has grown by 108.3% (from $1.93 per share (loss) to $0.16 per share).
- The most recent figure is from Pacira BioSciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: